Every material Form 8-K Westlake Chemical Partners LP has filed with the SEC since August 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Westlake Chemical Partners LP reported third quarter 2026 net income attributable to the partnership of $16.2 million, or $0.46 per unit, up from $14.7 million, or $0.42 per unit, a year earlier. It also declared a quarterly distribution of $0.4714 per unit, its 49th consecutive quarterly payout, which is payable December 1, 2026 to unitholders of record as of November 13, 2026.
Total net sales were $314.5 million, up from $308.9 million in the third quarter of 2025.
MLP distributable cash flow was $18.0 million, up from $14.9 million a year earlier, and trailing twelve-month coverage was 1.09x.
Cash flows from operating activities were $122.2 million, up $17.0 million from $105.2 million, mainly due to more favorable working capital changes.
The partnership declared a distribution of $0.4714 per unit, payable December 1, 2026.
Westlake Chemical Partners LP appointed Tommy E. Darby as Vice President and Chief Accounting Officer of its general partner, effective immediately. He succeeds Jeffrey A. Holy, who moves to Vice President, Finance and Investor Relations. The change affects the partnership's senior accounting leadership, though the filing discloses no financial results or compensation terms.
Tommy E. Darby, age 45, appointed Vice President and Chief Accounting Officer effective August 31, 2026
Darby previously served as Vice President and Chief Accounting Officer of Pactiv Evergreen Inc. (now Novolex) from August 2022 to April 2025
Jeffrey A. Holy moves to Vice President, Finance and Investor Relations, succeeding Darby's predecessor role
Westlake Chemical Partners LP reported second quarter 2026 net income attributable to the Partnership of $14.2 million, or $0.40 per unit, compared with $14.6 million a year earlier, while total net sales were flat at $297.1 million. Operating cash flow rose to $129.8 million from $9.1 million and MLP distributable cash flow rose to $17.6 million from $15.0 million, and the board declared a $0.4714 per unit distribution, the 48th consecutive quarterly distribution.
Net income attributable to the Partnership was $14.2 million, or $0.40 per limited partner unit, versus $14.6 million in Q2 2025.
Total net sales were $297.1 million, essentially unchanged from $297.1 million in Q2 2025.
MLP distributable cash flow was $17.6 million, up from $15.0 million; trailing twelve-month coverage ratio was 1.04x.
The $0.4714 per unit distribution is payable August 28, 2026 to unitholders of record as of August 13, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Westlake Chemical Partners LP filing is on SEC EDGAR ↗. 8-K briefs of other companies →